Evidence map›Paper›PMID 40643436›Full record

ReviewTurk patoloji dergisi2026

Primary Cutaneous Adiaspiromycosis: A Case Report and Review of the Literature.

Sateesh Chavan S, Chandrashekar T N, Arathi S, Sunitha Vernekar

Abstract readCase ReportsReview
In one paragraph

Review in Turk patoloji dergisi, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sateesh Chavan SDepartment of Pathology, Karnataka Medical College & Research Institute (KMC RI), KARNATAKA, INDIA.
Chandrashekar T NDepartment of Pathology, Shivamogga Institute of Medical Sciences, KARNATAKA, INDIA.
Arathi SDepartment of Pathology, Karnataka Medical College & Research Institute (KMC RI), KARNATAKA, INDIA.
Sunitha VernekarDepartment of Pathology, Karnataka Medical College & Research Institute (KMC RI), KARNATAKA, INDIA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo document a case of primary cutaneous Adiaspiromycosis.

introductionAdiaspiromycosis is a rare emerging fungal infection caused by Chrysosporium Parvum var Crescens now called as "Emmonsia Crescens" belonging to the genus Emmonsia, order Onygenales, family Ajellomycetes. CASE REPORT: A 38-year-old male presented with an ulcerated nodule over the infra-axillary region with itching for 3 months. The lesion began as small nodule slowly growing to attain the present size. His routine investigations were within normal limits. Serological tests such as HBsAg and HIV were nonreactive. Fine needle aspiration cytology showed 'suppurative granulomatous' inflammation. The nodule was excised and sent for histopathological examination. Histopathology showed numerous noncaseating granulomas and suppuration. Amidst suppuration, as well as inside the giant cells and within granulomas, numerous varying sized, thick-walled, round to oval 'adiaspores' were seen. There was no evidence of budding or septation or endosporulation. They were PAS and GMS positive. He was treated with topical luliconazole and oral fluconazole. There was no recurrence on follow up of one years.

conclusionAdiaspiromycosis is a rare fungal infection and primary cutaneous involvement is a rare distinct entity. Detailed morphological assessment in histopathology is essential for its identification as the organisms are difficult to isolate in fungal culture from human clinical material.

Indexed as

ChrysosporiumDermatomycosesAdultAntifungal AgentsHumansMaleAntifungal Agents

Identifiers

PMID40643436
PMCPMC13600669

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.